Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs

Literals

vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85116528381&origin=inward
dcterms:title
- Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs
bibo:doi
- 10.3389/fphar.2021.648262
fabio:hasPublicationYear
- 2021
dcterms:contributor
- Macias Y. et al.
ou:tipoPublicacion
- Article
vivo:identifier
- 2021-770
ou:eid
- 2-s2.0-85116528381
ou:bibtex
- @article{PMID:34621165, title = {Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs.}, author = {Macías Y and García-Menaya JM and Martí M and Cordobés C and Jurado-Escobar R and Cornejo-García JA and Torres MJ and Blanca-López N and Canto G and Blanca M and Laguna JJ and Agúndez JAG}, doi = {10.3389/fphar.2021.648262}, journal = {Frontiers in pharmacology}, year = {2021} }
bibo:eissn
- 1663-9812
dcterms:publisher
- Frontiers in Pharmacology
dcterms:creator
- Macías Y.
ou:urlOrcid
- http://europepmc.org/abstract/med/34621165
ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85116528381&origin=inward
ou:vecesCitado
- 3
bibo:volume
- 12